$AGN, $AGR, $BP, $EPZM
Below is a list of Wall Street’s Top analysts outlook for Key issues for Wednesday, as follows:
Allergan PLC (NYSE:AGN) was started with a Buy rating and assigned a 220 price target at Citigroup.
Avangrid Inc. (NYSE:AGR) was maintained as Buy with a 55 fair value at Janney. Merrill Lynch maintained it as Buy with a 54 price objective.
BP PLC (NYSE:BP) was raised to Buy from Neutral with a 54 price target at Goldman Sachs. BP’s American depository shares finished at 44.24 Tuesday. The consensus price target is 45.20, the 52-wk trading range is 33.90 – 44.62.
Epizyme Inc. (NASDAQ:EPZM) was maintained as Outperform but the price target was cut to 20 from 24 at Wedbush. The firm believes that the secondary malignancy causing a partial hold looks to be a 1-off event and the long-term thesis remains intact. Shares finish at 13.oo Tuesday.
Latest posts by Paul Ebeling (see all)
- The 5 Safest Cities in the World - October 13, 2019
- Box Office: ‘Joker’ Laughs with another $55-M in North America - October 13, 2019
- US Q-3 Earnings, Here They Come - October 13, 2019